Patents by Inventor J. Kenneth

J. Kenneth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951619
    Abstract: Cable-actuated differential enabling N degrees of freedom provided by a plurality of pulleys and at least N+1 tensioning cables. The cable-actuated differential increases a dynamic force range by minimizing co-activation of the tensioning cables at any operating point. A cable-actuated differential having three cables provides motor based control of a 2 DOF joint that can be applied to robots or teleoperation. A cable-actuated mechanical differential having opposing bevel gears and a middle bevel gear meshed with the opposing gear allows an output connector to controllably and independently rotate about the x axis or y axis via three operational modes without backlash.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: April 9, 2024
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: J. Kenneth Salisbury, Jr., Alex Nathan Kahn
  • Publication number: 20230285505
    Abstract: The present invention provides a method of treating pathological inflammation in a patient comprising: administering to the patient a multivalent structured polypeptide comprising multiple copies of the therapeutic peptide. The present invention also provides a kit, comprising: a multivalent structured polypeptide comprising multiple copies of the therapeutic peptide; and instructions teaching administration of the multivalent structured polypeptide to a patient having atopic dermatitis.
    Type: Application
    Filed: June 24, 2021
    Publication date: September 14, 2023
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Publication number: 20230173669
    Abstract: Systems and methods for facilitating handoffs between a robot and a counterpart in accordance with embodiments of the invention are illustrated. One embodiment includes a method for controlling a robot to handoff an object. The method includes steps for presenting an object to a receiver, moving an object to interrogate a grip stiffness of the receiver, and measuring a response to the moving using a set of one or more sensors. The method further includes steps for computing the grip stiffness of the receiver based on the measured response and determining whether to release the object based on the computed grip stiffness.
    Type: Application
    Filed: December 2, 2022
    Publication date: June 8, 2023
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Elizabeth Bianchini, Prateek Verma, J. Kenneth Salisbury, JR., Etienne Chassaing
  • Publication number: 20220331394
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a peptide or multivalent polypeptide, and an anti-cancer agent. In some embodiments, the anti-cancer agent is conjugated to the peptide or multivalent polypeptide. The present disclosure also relates to a method of treating cancer or reducing cancer cell proliferation using the peptide or multivalent polypeptide. In some aspects, the peptide or multivalent polypeptide enhances the efficacy of the anti-cancer agent, the targeting of the anti-cancer agent to the cancer cells, or both.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 20, 2022
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Patent number: 11376307
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a peptide or multivalent polypeptide, and an anti-cancer agent. In some embodiments, the anti-cancer agent is conjugated to the peptide or multivalent polypeptide. The present disclosure also relates to a method of treating cancer or reducing cancer cell proliferation using the peptide or multivalent polypeptide. In some aspects, the peptide or multivalent polypeptide enhances the efficacy of the anti-cancer agent, the targeting of the anti-cancer agent to the cancer cells, or both.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: July 5, 2022
    Assignee: Susavion Biosciences, Inc.
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Publication number: 20220002400
    Abstract: Methods of treating influenza A are provided, comprising administering to a subject at least one agent selected from a WDR7 inhibitor, a CCDC115 inhibitor, a TMEM199 inhibitor, and a CMTR1 inhibitor.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 6, 2022
    Inventors: Bo Li, Nir Hacohen, J. Kenneth Baillie
  • Publication number: 20210069285
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a peptide or multivalent polypeptide, and an anti-cancer agent. In some embodiments, the anti-cancer agent is conjugated to the peptide or multivalent polypeptide. The present disclosure also relates to a method of treating cancer or reducing cancer cell proliferation using the peptide or multivalent polypeptide. In some aspects, the peptide or multivalent polypeptide enhances the efficacy of the anti-cancer agent, the targeting of the anti-cancer agent to the cancer cells, or both.
    Type: Application
    Filed: January 3, 2019
    Publication date: March 11, 2021
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Patent number: 10941821
    Abstract: A four-state joint brake module is provided to selectably stop or allow motion in both directions resulting in a mechanism that has four possible states: 1) allowing rotation only in a clockwise direction, 2) allowing rotation only in a counter-clockwise direction, 3) allowing free rotation in both directions, and 4) stopping motion in both directions. In robotic and other motion control applications the use of this four-state joint brake module in a multi-segmented linkage allows for position holding without continuous application of power and “fail safe” behavior. It further allows for the ability to toggle this useful state behavior independently in either direction and is relevant for robotic applications.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: March 9, 2021
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: J. Kenneth Salisbury, Jr., Peter Gerrit Lowe, Austin D. Epps
  • Patent number: 10821151
    Abstract: The methods and compounds disclosed herein are useful in treating a subject having cancer or a viral infection by modulating the innate and adaptive immune systems typically by both inhibiting the function of inhibitory receptors and enhancing activity of activating receptors. Preferred therapeutic compositions comprise a carrier; at least one agent selected from the group consisting of: an anti-inflammatory agent, a cytotoxic T cell proliferation agent, or a NK cell proliferation agent; and a therapeutic peptide of the invention. In certain embodiments the compositions further include a second therapeutic peptide and/or an immunoglobulin admixed therewith in an amount sufficient to enhance passive immunoprotection in the subject.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: November 3, 2020
    Assignee: Susavion Biosciences, Inc.
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Patent number: 10624965
    Abstract: The present invention relates to compositions and kits comprising a peptide that activate the immune response and methods of using the composition for immunotherapy and cancer treatments. The peptide comprises an active peptide sequence of VQATQSNQHTPR. In some embodiments, the peptide may be tetravalent. For example, the peptide has the structure [(VQATQSNQHTPRGGGS)2K]2K—NH2. In some embodiments, the compositions and methods are directed to the treatment of cancer and/or infections.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: April 21, 2020
    Assignee: Susavion Biosciences, Inc.
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Publication number: 20200047332
    Abstract: Cable-actuated differential enabling N degrees of freedom provided by a plurality of pulleys and at least N+1 tensioning cables. The cable-actuated differential increases a dynamic force range by minimizing co-activation of the tensioning cables at any operating point. A cable-actuated differential having three cables provides motor based control of a 2 DOF joint that can be applied to robots or teleoperation. A cable-actuated mechanical differential having opposing bevel gears and a middle bevel gear meshed with the opposing gear allows an output connector to controllably and independently rotate about the x axis or y axis via three operational modes without backlash.
    Type: Application
    Filed: April 25, 2018
    Publication date: February 13, 2020
    Inventors: J Kenneth. Salisbury, JR., Alex Nathan Kahn
  • Publication number: 20190360538
    Abstract: A four-state joint brake module is provided to selectably stop or allow motion in both directions resulting in a mechanism that has four possible states: 1) allowing rotation only in a clockwise direction, 2) allowing rotation only in a counter-clockwise direction, 3) allowing free rotation in both directions, and 4) stopping motion in both directions. In robotic and other motion control applications the use of this four-state joint brake module in a multi-segmented linkage allows for position holding without continuous application of power and “fail safe” behavior. It further allows for the ability to toggle this useful state behavior independently in either direction is relevant for robotic applications.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Inventors: J. Kenneth Salisbury, JR., Peter Gerrit Lowe, Austin D. Epps
  • Publication number: 20190328826
    Abstract: The methods and compounds disclosed herein are useful in treating a subject having cancer or a viral infection by modulating the innate and adaptive immune systems typically by both inhibiting the function of inhibitory receptors and enhancing activity of activating receptors. Preferred therapeutic compositions comprise a carrier; at least one agent selected from the group consisting of: an anti-inflammatory agent, a cytotoxic T cell proliferation agent, or a NK cell proliferation agent; and a therapeutic peptide of the invention. In certain embodiments the compositions further include a second therapeutic peptide and/or an immunoglobulin admixed therewith in an amount sufficient to enhance passive immunoprotection in the subject.
    Type: Application
    Filed: July 15, 2019
    Publication date: October 31, 2019
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Patent number: 10350260
    Abstract: The methods and compounds disclosed herein are useful in treating a subject having cancer or a viral infection by modulating the innate and adaptive immune systems typically by both inhibiting the function of inhibitory receptors and enhancing activity of activating receptors. Preferred therapeutic compositions comprise a carrier; at least one agent selected from the group consisting of: an anti-inflammatory agent, a cytotoxic T cell proliferation agent, or a NK cell proliferation agent; and a therapeutic peptide of the invention. In certain embodiments the compositions further include a second therapeutic peptide and/or an immunoglobulin admixed therewith in an amount sufficient to enhance passive immunoprotection in the subject.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: July 16, 2019
    Assignee: Susavion Biosciences, Inc.
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Publication number: 20190167789
    Abstract: The present invention relates to compositions and kits comprising a peptide that activate the immune response and methods of using the composition for immunotherapy and cancer treatments. The peptide comprises an active peptide sequence of VQATQSNQHTPR. In some embodiments, the peptide may be tetravalent. For example, the peptide has the structure [(VQATQSNQHTPRGGGS)2K]2K-NH2. In some embodiments, the compositions and methods are directed to the treatment of cancer and/or infections.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 6, 2019
    Inventors: Laura L. Eggink, J. Kenneth Hoober
  • Patent number: 10271909
    Abstract: Systems and methods for performing robotically-assisted surgical procedures on a patient enable an image display device to provide an operator with auxiliary information related to the surgical procedure, in addition to providing an image of the surgical site itself. The systems and methods allow an operator to selectively access and reference auxiliary information on the image display device during the performance of a surgical procedure.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: April 30, 2019
    Assignee: Intuitive Surgical Operations, Inc.
    Inventors: Gary S. Guthart, David S. Mintz, Gunter D. Niemeyer, J. Kenneth Salisbury, Jr., Robert G. Younge
  • Publication number: 20190090967
    Abstract: Systems and methods for performing robotically-assisted surgical procedures on a patient enable an image display device to provide an operator with auxiliary information related to the surgical procedure, in addition to providing an image of the surgical site itself. The systems and methods allow an operator to selectively access and reference auxiliary information on the image display device during the performance of a surgical procedure.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 28, 2019
    Inventors: Gary S. Guthart, David S. Mintz, Gunter D. Niemeyer, J. Kenneth Salisbury, JR., Robert G. Younge
  • Patent number: 10232194
    Abstract: An imaging probe manipulator for use during a medical procedure includes a first manipulator linkage having a connector configured to attach to an imaging probe, a second manipulator linkage coupled to the first manipulator linkage at a first joint a third manipulator linkage coupled to the first or second manipulator linkage at a second joint. The first joint or the second joint has a degree of freedom. The imaging probe manipulator includes a force control transmission linked to the degree of freedom. The force control transmission component is configured to maintain a pre-determined force on the imaging probe when the imaging probe is in contact with a patient.
    Type: Grant
    Filed: July 29, 2013
    Date of Patent: March 19, 2019
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Jeffrey S. Schlosser, Dimitre H. Hristov, J. Kenneth Salisbury, Jr.
  • Publication number: 20180185110
    Abstract: A multi-user medical robotic system for collaboration or training in minimally invasive surgical procedures includes first and second master input devices, a first slave robotic mechanism, and at least one processor configured to generate a first slave command for the first slave robotic mechanism by switchably using one or both of a first command indicative of manipulation of the first master input device by a first user and a second command indicative of manipulation of the second master input device by a second user. To facilitate the collaboration or training, both first and second users communicate with each other through an audio system and see the minimally invasive surgery site on first and second displays respectively viewable by the first and second users.
    Type: Application
    Filed: January 10, 2018
    Publication date: July 5, 2018
    Inventors: Rajesh Kumar, Brian D. Hoffman, Giuseppe Maria Prisco, David Q. Larkin, William C. Nowlin, Frederic H. Moll, Stephen J. Blumenkranz, Gunter D. Niemeyer, J. Kenneth Salisbury, JR., Yulun Wang, Modjtaba Ghodoussi, Darrin R. Uecker, James W. Wright, Amante A. Mangaser, Ranjan Mukherjee
  • Patent number: RE47245
    Abstract: This present invention is directed to peptides, compositions, and methods for modulating endogenous cytokine expression in a subject. More specifically, the invention provides peptides useful in regulating the release of a specific pattern of cytokines that promote angiogenesis and/or can be used to modulate the immune system of a subject.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: February 19, 2019
    Assignee: Susavion Biosciences, Inc.
    Inventors: Laura L. Eggink, J. Kenneth Hoober